Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using continuous glucose monitors for diabetes management after hospital discharge

Official title: Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Run by Vanderbilt University Medical Center · NCT06852950 · Data updated 2026-11-12

This study is testing if using continuous glucose monitors can help adults with diabetes manage their blood sugar better after leaving the hospital.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedMarch 9, 2025
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedMarch 5, 2026
Trial IDNCT06852950 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are non-pregnant adults aged 18 and older with hyperglycemia requiring insulin therapy during hospitalization.

Probably not a fit

Patients currently using continuous glucose monitoring systems or those with certain medical conditions, such as recent chemotherapy or planned major surgery, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on enhancing diabetes management for patients transitioning from hospital to home by utilizing continuous glucose monitoring systems. It aims to increase patient awareness and satisfaction regarding blood glucose monitoring through the use of devices like the Libre 3 Plus and Dexcom G7. Eligible participants include adults with hyperglycemia requiring insulin therapy, who will be monitored for their glucose levels post-discharge. The study seeks to evaluate the effectiveness of these monitoring systems in improving patient outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to better diabetes management and improved patient satisfaction for individuals transitioning from hospital care to home.

How similar studies have gone: Other studies have shown positive outcomes with continuous glucose monitoring in diabetes management, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC
* Able to give informed consent
* Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge
* POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL
* Need glucose readings greater than or equal to one time per day
* Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone

Exclusion Criteria:

* Currently using Libre 3 Plus or Dexcom G7 CGMS during hospitalization or have used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months
* Does not have smartphone compatible with Libre 3 App or Dexcom G7 App
* Received chemotherapy during current hospitalization
* Planning on major surgery within 10-15 days
* Hemodialysis or peritoneal dialysis
* Requiring vasopressors, intubation, sedation, or admission to an intensive care unit
* Vitamin C use of more than 500 milligrams per day
* Hydroxyurea use
* Acetaminophen use of more than 4 grams per day or 1 gram every 6 hours
* Significant pitting edema (3+ or greater) i.e. cirrhosis with ascites, congestive heart failure with edema, nephrotic syndrome, or signs of poor perfusion
* Presentation in diabetic ketoacidosis or hyperosmotic nonketotic state
* Skin allergy to adhesives

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.